162 related articles for article (PubMed ID: 33082093)
21. Regulations governing veterinary medicinal products containing genetically modified organisms in the European community.
Moulin G
Rev Sci Tech; 2005 Apr; 24(1):101-7. PubMed ID: 16110880
[TBL] [Abstract][Full Text] [Related]
22. [The EU law on genetically modified organisms: the European Commission changes the strategy in order to allow, restrict, or prohibit its culture].
González Vaqué L
Rev Derecho Genoma Hum; 2010; (33):217-40. PubMed ID: 21510337
[TBL] [Abstract][Full Text] [Related]
23. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
Oliveira SC; de Magalhães MTQ; Homan EJ
Front Immunol; 2020; 11():587615. PubMed ID: 33193414
[TBL] [Abstract][Full Text] [Related]
24. Genetically modified organisms: do the benefits outweigh the risks?
Hug K
Medicina (Kaunas); 2008; 44(2):87-99. PubMed ID: 18344661
[TBL] [Abstract][Full Text] [Related]
25. Regulation of genetically modified organisms (GMOs) in the European Union: principles of risk assessment.
Anadón A; Roda L; Martínez-Larrañaga MR
Vet Hum Toxicol; 2004 Dec; 46(6):340-1. PubMed ID: 15587259
[TBL] [Abstract][Full Text] [Related]
26. Hurdles of environmental risk assessment procedures for advanced therapy medicinal products: comparison between the European Union and the United States.
Iglesias-Lopez C; Obach M; Vallano A; Agustí A; Montané J
Crit Rev Toxicol; 2019 Aug; 49(7):580-596. PubMed ID: 31846383
[TBL] [Abstract][Full Text] [Related]
27. Gene therapy legislation in The Netherlands.
Bleijs DA; Haenen IT; Bergmans JE
J Gene Med; 2007 Oct; 9(10):904-9. PubMed ID: 17721872
[TBL] [Abstract][Full Text] [Related]
28. SARS Coronavirus-2 variant tracing within the first Coronavirus Disease 19 clusters in northern Germany.
Pfefferle S; Günther T; Kobbe R; Czech-Sioli M; Nörz D; Santer R; Oh J; Kluge S; Oestereich L; Peldschus K; Indenbirken D; Huang J; Grundhoff A; Aepfelbacher M; Knobloch JK; Lütgehetmann M; Fischer N
Clin Microbiol Infect; 2021 Jan; 27(1):130.e5-130.e8. PubMed ID: 33007476
[TBL] [Abstract][Full Text] [Related]
29. Options to Reform the European Union Legislation on GMOs: Risk Governance.
Eriksson D; Custers R; Edvardsson Björnberg K; Hansson SO; Purnhagen K; Qaim M; Romeis J; Schiemann J; Schleissing S; Tosun J; Visser RGF
Trends Biotechnol; 2020 Apr; 38(4):349-351. PubMed ID: 32171418
[TBL] [Abstract][Full Text] [Related]
30. Neutralizing SARS-CoV-2.
Poeschla E
Elife; 2020 Dec; 9():. PubMed ID: 33320086
[TBL] [Abstract][Full Text] [Related]
31. Priority setting during the COVID-19 pandemic: going beyond vaccines.
Williams I; Essue B; Nouvet E; Sandman L; Razavi SD; Noorulhuda M; Goold S; Danis M; Biemba G; Abelson J; Kapiriri L
BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33461979
[No Abstract] [Full Text] [Related]
32. Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.
Joffe S
JAMA; 2021 Jan; 325(3):221-222. PubMed ID: 33315069
[No Abstract] [Full Text] [Related]
33. Rationing of Civilian Coronavirus Disease 2019 Vaccines While Supplies Are Limited.
Zimmerman RK; South-Paul JE; Poland GA
J Infect Dis; 2020 Nov; 222(11):1776-1779. PubMed ID: 32894861
[No Abstract] [Full Text] [Related]
34. The UK has approved a COVID vaccine - here's what scientists now want to know.
Ledford H; Cyranoski D; Van Noorden R
Nature; 2020 Dec; 588(7837):205-206. PubMed ID: 33288887
[No Abstract] [Full Text] [Related]
35. Genetic Material and Sequence Data to Protect Global Health in the Light of Pandemic Outbreaks: Mapping the Legal Landscape under European and International Law.
Seitz C
Eur J Health Law; 2020 Jun; 27(3):232-241. PubMed ID: 33652395
[TBL] [Abstract][Full Text] [Related]
36. Free licensing of vaccines to end the COVID-19 crisis.
Bozorgmehr K; Jahn R; Stuckler D; McKee M
Lancet; 2021 Apr; 397(10281):1261-1262. PubMed ID: 33743843
[No Abstract] [Full Text] [Related]
37. [Immunity against SARS-CoV-2: walking to the vaccination].
Rodríguez Hernández C; Sanz Moreno L
Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536
[TBL] [Abstract][Full Text] [Related]
38. Traceability of genetically modified organisms.
Aarts HJ; van Rie JP; Kok EJ
Expert Rev Mol Diagn; 2002 Jan; 2(1):69-76. PubMed ID: 11963810
[TBL] [Abstract][Full Text] [Related]
39. Current Status of Diagnostic Testing for SARS-CoV-2 Infection and Future Developments: A Review.
Gao J; Quan L
Med Sci Monit; 2020 Dec; 26():e928552. PubMed ID: 33332288
[TBL] [Abstract][Full Text] [Related]
40. The Science and Art of Vaccinology During the COVID-19 Pandemic.
Romero JR; Bernstein HH
Pediatr Ann; 2020 Dec; 49(12):e506-e508. PubMed ID: 33290567
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
